Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Cancer J. 2022 May-Jun;28(3):208–223. doi: 10.1097/PPO.0000000000000591

Figure 15.

Figure 15

Sex-specific meta-analyses with careful separation of women from men and primary from secondary prevention trials to analyze primary cardiovascular disease prevention trials show that statin therapy does not statistically significantly reduce coronary heart disease (CHD) in women as it does in men. In both women and men in primary cardiovascular disease prevention, statin therapy does not reduce all-cause mortality. Upper panel from Petretta M, et al. (34). Lower Panel from Brugts JJ, et al. (36). CI = confidence interval